(19)
(11) EP 1 165 502 A1

(12)

(43) Date of publication:
02.01.2002 Bulletin 2002/01

(21) Application number: 00922557.4

(22) Date of filing: 27.03.2000
(51) International Patent Classification (IPC)7C07C 311/29, C07C 235/60, C07C 317/22, C07C 323/67, C07D 213/75, C07D 213/76, C07D 295/13, C07D 295/185, C07D 295/192, C07D 295/26, A61K 31/16, A61K 31/18, A61P 9/00
(86) International application number:
PCT/EP0002/683
(87) International publication number:
WO 0058/279 (05.10.2000 Gazette 2000/40)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.03.1999 US 280105

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE CY 
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1230 Wien (AT)

    AT 

(72) Inventor:
  • KUKKOLA, Paivi, Jaana
    Whitehouse Station, NJ 08889 (US)

(74) Representative: Becker, Konrad et al
Novartis AG, Corporate Intellectual Property, Patent & Trademark Department
4002 Basel
4002 Basel (CH)

   


(54) DIARYL DERIVATIVES AND THEIR USE AS MEDICAMENTS